BIANCA REGAN: Open Payments
NPI 1003505876 · FLEMINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 49 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $780 · 2025 $944
Food & beverage: $944
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $159 |
| Phathom Pharmaceuticals, Inc. | 10 | $133 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $118 |
| PFIZER INC. | 6 | $92 |
| Madrigal Pharmaceuticals | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Braintree Laboratories, Inc. | 3 | $61 |
| Lilly USA, LLC | 3 | $58 |
| Janssen Biotech, Inc. | 3 | $57 |
| Novo Nordisk Inc | 2 | $41 |
Products named: SKYRIZI, VOQUEZNA, XIFAXAN, REZDIFFRA, ENTYVIO, XELJANZ, SUFLAVE, OMVOH.
Industry payments across NJ — which companies pay providers there.
